These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32441496)

  • 1. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
    Yahya AS; Khawaja S; Chukwuma J
    Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
    [No Abstract]   [Full Text] [Related]  

  • 2. The COVID-19 Pandemic and Mayo Clinic Proceedings.
    Nath KA
    Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
    Javelot H; El-Hage W; Meyer G; Becker G; Michel B; Hingray C
    Br J Clin Pharmacol; 2020 Jun; 86(6):1176-1177. PubMed ID: 32350872
    [No Abstract]   [Full Text] [Related]  

  • 4. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine.
    Monzani A; Genoni G; Scopinaro A; Pistis G; Kozel D; Secco GG
    Eur J Clin Invest; 2020 Jun; 50(6):e13258. PubMed ID: 32356580
    [No Abstract]   [Full Text] [Related]  

  • 5. The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
    Uvais NA
    Prim Care Companion CNS Disord; 2020 Apr; 22(3):. PubMed ID: 32369686
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
    Halm MA
    Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Potential harms associated with 4-aminoquinoline treatment].
    Svensson M
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32365215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
    Oren O; Yang EH; Gluckman TJ; Michos ED; Blumenthal RS; Gersh BJ
    Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008688. PubMed ID: 32436730
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
    Fatima U; Rizvi SSA; Fatima S; Hassan MI
    J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulators split on antimalarials for COVID-19.
    Jaffe S
    Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].
    Zaidel EJ; Wyss Quintana FS; Sosa Liprandi Á; Mendoza I; Márquez MF; Nuñez E; Barbosa M; Baranchuk A
    Medicina (B Aires); 2020; 80(3):271-274. PubMed ID: 32442941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of chloroquine and COVID-19.
    Touret F; de Lamballerie X
    Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
    Tomcsányi J; Tomcsányi K
    Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?
    Kamp TJ; Hamdan MH; January CT
    J Am Heart Assoc; 2020 Jun; 9(12):e016887. PubMed ID: 32463308
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
    Hamm BS; Rosenthal LJ
    Psychosomatics; 2020; 61(6):597-606. PubMed ID: 32800347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
    Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
    Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
    [No Abstract]   [Full Text] [Related]  

  • 19. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor.
    Danjuma MI; Sinha U; Fatima H; Mohamed MFH; Nathoe H
    Eur J Clin Invest; 2020 Nov; 50(11):e13407. PubMed ID: 32918829
    [No Abstract]   [Full Text] [Related]  

  • 20. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.